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Abstract
Background: Screening of various gene markers such as single nucleotide polymorphism (SNP)
and correlation between these markers and development of multifactorial disease have previously
been studied. Here, we propose a susceptible marker-selectable artificial neural network (ANN)
for predicting development of allergic disease.
Results: To predict development of childhood allergic asthma (CAA) and select susceptible SNPs,
we used an ANN with a parameter decreasing method (PDM) to analyze 25 SNPs of 17 genes in
344 Japanese people, and select 10 susceptible SNPs of CAA. The accuracy of the ANN model with
10 SNPs was 97.7% for learning data and 74.4% for evaluation data. Important combinations were
determined by effective combination value (ECV) defined in the present paper. Effective 2-SNP or
3-SNP combinations were found to be concentrated among the 10 selected SNPs.
Conclusion: ANN can reliably select SNP combinations that are associated with CAA. Thus, the
ANN can be used to characterize development of complex diseases caused by multiple factors.
This is the first report of automatic selection of SNPs related to development of multifactorial
disease from SNP data of more than 300 patients.
Background
In recent years, the number of patients suffering from
allergic asthma has increased [1], and allergic diseases
including asthma have become a social problem affecting
medical costs and quality of life. Allergic asthma is a com-
plex disorder characterized by airway inflammation,
bronchial hyperresponsiveness and reversible airway
obstruction. Elevated numbers of activated Th2 cells, mast
cells and eosinophils in the bronchial mucosa cause cer-
tain features of asthma, including increased serum IgE lev-
els in allergic asthma. The available data suggest that there
are many potential susceptible genes for allergic asthma,
including genes for cytokines, receptors, transcription fac-
tors, immune recognition and regulation of lipid
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mediator generation. A few susceptible genes for allergic
asthma have been identified that may be associated with
the asthmatic phenotype [2-4], but definite susceptible
genes have not been identified yet. Thus, large-scale anal-
ysis of gene markers is needed, along with identification
of association between these genetic polymorphisms and
the asthmatic phenotype, and its development mecha-
nism. It has been reported that the human genome has 3
to 10 million single nucleotide polymorphisms (SNPs). A
SNP in a coding region can cause amino acid substitution,
resulting in functional modification of the protein; a SNP
in a promoter region can affect transcriptional regulation;
and a SNP in an intron region can affect splicing and
expression of the gene. Thus, SNPs can be highly inform-
ative for identifying genetic factors of multifactorial dis-
ease such as allergic asthma.
In the present study, we analyzed associations between
SNPs and childhood allergic asthma (CAA), which is
more strongly influenced by genetic factors than other
types of allergic asthma. We performed this analysis using
an artificial neural network (ANN), which is a computer-
based algorithm that can be trained to recognize and cat-
egorize complex patterns [5-8]. ANNs have been used for
discrimination between subtly different clinical disease
lesions; e.g., premalignant lesion Barrett's versus esopha-
geal cancer, based on microarray data [6]. In a previous
study, we performed severity assessment of senile demen-
tia of Alzheimer type using ANN modeling of electroen-
cephalogram data. The average error of the ANN model
for assessment scale (HDS-R) score was 2.64 points out of
30 [7]. We have also used an ANN for prediction of 4 aller-
gic diseases using SNP data [8]; 82 subjects with data for
6 SNPs were analyzed, and the ANN model predicted
diagnosis with accuracy of more than 78%. Thus, we have
achieved sufficiently high accuracy with ANNs using rela-
tively little SNP data.
Here, we propose an ANN model (its structure is shown in
Figure 1) suitable to diagnostic prediction of 172 subjects
with CAA and 172 healthy subjects, using 25 SNPs in 17
genes shown in Table 1. For comparison with ANN, we
also used logistic regression (LR) analysis, which is cur-
rently used to analyze medical statistics and equivalent to
ANN with a single hidden node [9]. In order to selectively
identify susceptible SNPs, a susceptible marker-selectable
ANN is proposed, in which a parameter decreasing
method (PDM) is incorporated. Information on obtain-
ing the execute code, example data and documentation of
this software is available at http://www.nubio.nagoya-
u.ac.jp/proc/english/indexe.htm. Associations between
combinations of important SNPs and CAA pathogenesis
were investigated. A χ2 test was performed for all 2-SNP
and 3-SNP combinations.
Results
SNPs selected for diagnostic prediction with ANN
Several reports have suggested linkage between asthma
and chromosomes. For example, genes in the 5q31-5q33
region code for Th2-type cytokines (IL-4, IL-13, which reg-
ulate B cell heavy-chain class-switching to IgE production)
[10] and ADRB2 (which mediates airway smooth muscle
relaxation and protects against bronchial hyperreactivity)
[11,12]. IL-4 operates via the IL-4 receptor (IL-4R), which
is encoded by a gene in chromosomal region 16q12. Mice
deficient in the IL-4Rα chain lack IgE production and Th2
inflammatory reactions, and it has been shown that total
IgE level is dependent on Ile50Val substitution [13]. In the
present study, we analyzed 25 SNPs (Table 1) in 17 genes
known to be associated with development of asthma.
Association between these SNPs and CAA was assessed by
P-value. As shown in Table 1, 21 of these 25 SNPs had a
P-value greater than 0.1. The P-values of CysLT2 (108 C/
A), IL-4Rα (148 G/A), ADRB2 (265 A/G) and C5 (4266 G/
A) were 0.0036, 0.0155, 0.0541 and 0.0581, respectively.
When CysLT2 (108 C/A), which had the lowest P-value of
25 SNPs, was used for discrimination between case and
control as a sole factor, prediction accuracy was 54.4%,
and the sensitivity and specificity was 12.8% and 95.9%,
respectively, compared with the number of case and con-
trol subjects to assess discrimination performance
Structure of ANN Figure 1
Structure of ANN. For the analysis of 25 SNPs, 50 input layer 
units were provided. The number of hidden layer units was 
changed from the usual 6 to 10, to optimize the ANN for the 
highest possible prediction accuracy. The output layer had 
only 1 unit. Because the ANN model has connection weight 
parameters, which depend on the number of connection 
units, analysis of 25 SNPs with 6 hidden layer units requires 
306 connection weight parameters.
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(genotype CC; case 150, control 165, genotype CA or AA;
case 22, control 7). Thus, we constructed a susceptible
marker-selectable ANN model, which can discriminate
between cases and controls using the selected susceptible
SNPs, and which can include the association between
combinations of SNPs and development of CAA.
Diagnostic prediction using 25 SNPs
We used a three-layered ANN with input, hidden and out-
put layers (Figure 1). An ANN model and LR model, with
25 SNPs as input variables, were constructed with learning
data, and we performed diagnostic prediction with evalu-
ation data. The results of diagnostic prediction are shown
in Figure 2a,2b and Table 2a. The ANN had higher predic-
tion accuracy than LR. Accordingly, sensitivity and specif-
icity, with both evaluation data and learning data, were
higher for the ANN than for LR (Table 2a). In LR analysis,
Monte Carlo study was performed to evaluate the effect of
number of events per variable (EPV) [14]. It suggested that
at least 10 events per variable analyzed were desirable to
maintain the validity of the model. In the present study,
we used 172 events per group and 51 variables (25 SNPs
and 1 teacher value). LR would not have an enough power
for parameter selection, because 172 events per group is
small compared with that of variable. The construction of
optimized LR model should be furthermore investigated.
Selection of susceptible SNPs for CAA
Ritchie et al. [5] reported the optimization of the architec-
ture using genetic programming neural networks (GPNN)
[5]. If important SNPs were previously determined, opti-
mization of network architecture should be carried out.
Genetic programming neural networks have contributed
the construction of ANN model with high performance.
In the present study, however, many candidate SNPs were
used and the selection of SNPs is firstly desired. Therefore,
in order to extract SNPs closely associated with CAA, we
tried optimization of input variables by PDM in the ANN
model, while the architecture of a neural network was not
modified. Five PDM trials were performed. Figure 3 shows
typical results for change of accuracy during PDM proce-
dure. When input variables were excluded one by one to
preserve prediction accuracy (as described in Methods),
the accuracy began to decrease after the number of SNPs
used for modeling reached 10. When the number of SNPs
used for modeling decreased, coincidence of genotyping
pattern between cases and controls inevitably occurred.
When genotyping pattern of a case was coincident with
that of controls, the learning for model construction did
Table 1: Polymorphisms used in the present study.
Gene Polymorphism D.F.a P-Valueb
TGF-β -509 C/T 2 0.6299
IL-10 -571 C/A 2 0.1074
IL-4 -590 C/T 2 0.9085
IL-4Rα 148 G/A (Val50Ile) 2 0.0155
TXA2R 924 T/C (synonym) 1 0.5603
ADRB2 265 A/G (Arg16Gly) 2 0.0541
STAT6 2964 G/A 2 0.7881
FcεRIB 811 A/G (Glu237Gly) 1 0.5382
ITK 2860 G/A 2 0.9623
CysLT2 -580 T/C 2 0.7868
CysLT2 108 C/A 1 0.0036
CysLT2 2534 A/G 2 0.5664
IL-12B 1146 C/A 2 0.1154
IKAP 2446 A/C (Ile816Leu) 2 0.7988
IKAP 3214 T/A (Cys1072Ser) 2 0.2997
IKAP 3473 C/T (Pro1158Leu) 2 0.2779
C5 1155 A/G 2 0.1056
C5 4266 G/A 2 0.0581
C39 1 2  G / A 2 0 . 5 0 2 0
C3 1692 G/A 2 0.6993
C3 4896 C/T 2 0.7205
C5aR 1289 C/A 2 0.1211
C5aR 1337 C/T 1 0.2398
C3aR 1526 G/A 1 0.7366
IL-13 329 G/A (Arg110Gln) 2 0.7924
aDegree of freedom (see text). bAssociation between SNPs and CAA was evaluated as P-value, which was calculated with χ2 test.BMC Bioinformatics 2004, 5:120 http://www.biomedcentral.com/1471-2105/5/120
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not progress well. We investigated the rate of case subjects
whose genotype patterns were coincident with that of
control subjects at each step of PDM (Figure 3). Rate of
case subjects [%] in Figure 3 means N'case/Ncase. In this
case, N'case is the number of cases whose genotype pattern
is match to control's genotype pattern at least one control
(Ncase = 172 subjects). As shown in Figure 3, there was lit-
tle coincidence of genotype patterns when more than
approximately 7 SNPs were used in ANN modeling.
Therefore, the decrease in accuracy was considered to be
due to omission of a highly important SNP. The remain-
ing 10 SNPs were worth investigating as important factors.
To investigate the important SNPs, we counted the
number of SNPs that remained within the last 10 input
variables in 5 trials. The significance order of remaining
SNPs was listed, and a score of order ranging from 1 to 10
points was determined, based on the significance order.
The remaining SNPs were reordered according to sums of
scores, as shown in Table 3. We believe that SNPs with
higher scores are more important for development of
CAA, because significance of SNPs correlated with the
order of elimination via the PDM procedure described in
methods section. ANN models were reconstructed using
SNPs listed in Table 3. The number of input SNPs varied
from three (IL-4Rα (148 G/A), CysLT2 (2534 A/G) and IL-
10 (-571 C/A)) to 17 SNPs (all listed SNPs) according to
the order of Table 3. When more than 10 SNPs were used
as input variables, average accuracy for learning and eval-
uation data was high (Figure 4), and was almost equal to
that of the model using 25 SNPs. These results suggest that
the 10 SNPs selected in Table 3 are very important for pre-
diction of development of CAA.
The results of diagnostic prediction using the 10 SNPs
selected by PDM are shown in Figure 2c, and the accuracy,
Diagnostic prediction of ANN (a) and LR (b) using 25 SNPs, and prediction of ANN (c) and LR (d) using the 10 selected SNPs Figure 2
Diagnostic prediction of ANN (a) and LR (b) using 25 SNPs, and prediction of ANN (c) and LR (d) using the 10 selected SNPs. 
Prediction results of evaluation data are presented. Gray and white bars represent frequency of case subjects and control sub-
jects, respectively.
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sensitivity and specificity are shown in Table 2b. In the
ANN model, the accuracy, sensitivity and specificity with
evaluation data were again sufficiently high, and were
somewhat similar to the results from the analysis using 25
SNPs, although the number of input variables was mark-
edly smaller than in the analysis using 25 SNPs. In partic-
ular, sensitivity was significantly high (77.9%), indicating
that case subjects were more correctly diagnosed by this
model. To compare with the LR model, LR model consist-
ing of 10 SNPs selected by ANN was constructed (Figure
2d). As shown in Table 2b, the LR model constructed
showed low accuracy. This result indicates high perform-
ance of ANN modeling for CAA prediction although
selected SNPs would not be suitable for LR analysis. We
concluded that the ANN model constructed with 10 SNPs
could discriminate between cases and controls as precisely
as the model constructed with 25 SNPs.
Interaction between SNP and another SNP for CAA
To understand the importance of the 10 SNPs selected, we
analyzed combinations of these 10 SNPs. We paid partic-
ular attention to SNP combinations associated with CAA,
and assessed whether any combinations consisting of
SNPs selected by ANN were associated with CAA. The rela-
tionships between 2-SNP or 3-SNP combinations and
CAA development were examined by calculating P-value
Table 2: Accuracy, sensitivity and specificity of ANN and LR.
a
ANN accuracy [%] sensitivity [%] specificity [%]
learning 98.8 99.1 98.4
evaluation 73.3 74.4 72.1
LR accuracy [%] sensitivity [%] specificity [%]
learning 68.8 69.2 68.3
evaluation 48.3 45.3 51.2
b
ANN accuracy [%] sensitivity [%] specificity [%]
learning 97.7 98.0 97.5
evaluation 74.4 77.9 70.9
LR accuracy [%] sensitivity [%] specificity [%]
learning 59.4 57.8 60.9
evaluation 47.7 48.3 47.1
(a) with 25 SNPs.
(b) with 10 SNPs selected by PDM.
Effect of number of input variables on ANN model accuracy  during PDM procedure Figure 3
Effect of number of input variables on ANN model accuracy 
during PDM procedure. Closed triangles represent average 
accuracy for learning and evaluation data. Closed squares 
represent the rate of case subjects that means N'case/Ncase. In 
this case, N'case is the number of cases whose genotype pat-
tern is match to control's genotype pattern at least one con-
trol (Ncase = 172 subjects).
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using the χ2 test. In models using 10 SNPs selected by
PDM or the other 15 SNPs, the total number of 2-SNP
combinations and 3-SNP combinations (Ncomb) is 90
(10P2) or 210 (15P2), and 360 (10P3/2) or 1365 (15P3/2),
respectively. With respect to 2-SNP combination between
the SNP of interest and SNP A, P-value was calculated as
follows. When patients were limited with certain pattern
of another SNP, such as AA major homozygote of SNP A,
patient distribution of the SNP of interest was investi-
gated. With respect to 3-SNP combination, between the
SNP of interest, and SNP A and B, P-value was calculated
as follows. When patients were limited with certain pat-
tern of two other SNPs, such as AA major homozygote of
SNP A and BB major homozygote of SNP B, patient distri-
bution of the SNP of interest was investigated.
To evaluate P-value of the combination, the usual Bonfer-
roni correction of P-values was first investigated. To select
the 2-SNP combination accompanied with minimum
false positive, the criterion was P < 0.05/300. Here 300
cases correspond to 25C2. Under this severe condition,
there were no significant SNPs. As the same as 2-SNP
combination, any significant combination was not
obtained on 3-SNP combination under the threshold of P
< 0.05/2300. Next, to determine important combination,
P-value without Bonferroni correction was used, that is P
< 0.05. Results are shown in Table 4. In 2-SNP combina-
tion, there were 13 combinations with P < 0.05 among
total 90 combinations. In the case of 3-SNP, 72 combina-
tions with P < 0.05 were existed in 360 exhaustive combi-
nations. However, combinations possibly include several
false positive significant combinations. Therefore, we paid
attention to the SNP, of which P-value effectively
decreases by combining with genotype or allele of other
SNPs. We defined effective combination value (ECV).
ECV2 or ECV3 is the ratio of 2 or 3-SNPs P-value to the
product of each P-value. ECV is not indicator for avoiding
false positives but for evaluation of interaction. For
example, in 2 SNP combinations, when patients were lim-
ited with certain pattern of another SNP, such as AA major
homozygote of SNP A, patient distribution of the SNP X
of interest is investigated (P = Pax). If the 2-SNP combina-
tion is independent (no interaction) each other, Pax equals
multiplication of Pa and Px. ECV<1 means that the 2-SNP
combination is not independent and two SNPs have any
interaction each other.
The effect of ECV on number of effective combinations is
shown in Table 4. About half number of 2-SNP combina-
tion satisfied the condition ECV2<1 (NECV2<1  = 47).
Among 13 combinations with P < 0.05 mentioned above,
11 combination also satisfied the same condition
(NECV2<1,P = 11). When ECV2<0.5, NECV2<0.5 decreased the
number to 27 and 10 of NECV2<1,P = 11 still remained.
When ECV2<0.1, NECV2<0.1  became small and it was
thought that positive combination may be lost. In the case
of 3-SNP combination, only 20% of the total combina-
tion satisfied the condition P < 0.05. The combinations of
12% among the total combinations (43 combinations)
satisfied ECV3<1. All of these 43 combinations also satis-
fied the condition P < 0.05. From these results, it was
concluded that P < 0.05 is not strict criterion for 3-SNP
combination analysis. In the case of 2-SNP combination,
ECV2<0.5 was adequate as a selection of effective combi-
nation, because 77% of the combination with P < 0.05
still remained. From these consideration, we selected
these two evaluation bases (P-value and ECV) in order to
determine effective combinations and the combination
with NECV<0.5,P (P < 0.05 and ECV<0.5) was picked up. The
combinations were used for the following investigation.
The number of combination which satisfies the condi-
tion, P < 0.05 and ECV2<0.5 in 2-SNP combination and P
< 0.05 and ECV3<0.5 in 3-SNP combination was desig-
nated as Nef, the number of effective combination, respec-
tively (Table 5).
It is very important to clearly determine whether effective
combinations frequently occur among groups of 10 SNPs
selected by ANN modeling with PDM. It would be diffi-
cult to investigate the phenotypes associated with each of
such a large number of combinations. Identifying effec-
tive 2-SNP combinations using the conditions described
above is a useful method of identifying 2-SNP combina-
tions that merit further investigation. Ten effective
Reconstruction of ANN model using SNPs listed in Table 3 Figure 4
Reconstruction of ANN model using SNPs listed in Table 3. 
Closed triangles represent average accuracy for all data of 
learning and evaluation.
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combinations were found among the 10 SNPs selected by
ANN; 23 effective combinations were found between
those 10 SNPs and the remaining 15 SNPs; and 3 effective
combinations were found among the remaining 15 SNPs.
It is likely that the former 10 combinations are more
important than the latter 26 combinations, because the
ANN model constructed using only the selected 10 SNPs
exhibited sufficiently high accuracy to predict develop-
ment of CAA. Susceptible genes for development of a mul-
tifactorial disease like CAA can correctly classify many
subjects as cases or controls, and it is very important that
those genes involve SNP combinations that have impor-
tant interaction with high concentration ratio. We defined
the concentration ratio as the ratio of effective rate to ran-
dom selection rate. When the effective rate, Nef/ΣNef, was
calculated, it was found to be 0.28 (10/36) for the 10
Table 3: Ranking of SNPs selected by PDM.
SNP P-valuea n (/5)b point (/50)c
IL-4Rα (148 G/A) 0.0155 5 47
CysLT2 (2534 A/G) 0.5664 5 38
IL-10 (-571 C/A) 0.1074 5 27
C3 (4896 C/T) 0.7205 4 27
C3 (1692 G/A) 0.6993 2 18
IKAP (2446 A/C) 0.7988 5 17
IL-13 (329 G/A) 0.7924 4 16
C3 (912 G/A) 0.5020 3 16
STAT6 (2964 G/A) 0.7881 2 14
IL-4 (-590 C/T) 0.9085 2 13
.........................................................................................................................................................................................................................................................
IKAP (3473 C/T) 0.2779 2 12
ADRB2 (265 A/G) 0.0541 4 8
IKAP (3214 T/A) 0.2997 2 8
C5aR (1289 C/A) 0.1211 1 6
C5 (4266 G/A) 0.0581 1 5
CysLT2 (108 C/A) 0.0036 2 2
C3aR (1526 G/A) 0.7366 1 1
The 10 SNPs over the dotted line were used for the following experiments.
aP-value was calculated with χ2test.
bNumber of SNPs selected within last 10 input variables during PDM procedure (5 trials performed).
cPoint of SNPs selected within last 10 input variables during PDM procedure. The score of order ranged from 1 to 10 points, based on the 
significance order in 1 PDM procedure and totaled in 5 trials.
Table 4: Selection of effective combinations evaluated with two bases P-value and ECV among the 10 selected SNPs.
combination 2-SNP 3-SNP
Ncomb 90 360
13 72
47/11 43/43
27/10 25/25
6/5 3/3
aThe number of combination that satisfies the following conditions: P-value < 0.05.
bThe number of combination that satisfies the conditions: ECV<1, 0.5 and 0.1, respectively.
cThe number of combination that satisfies the conditions: both ECV<1, 0.5, 0.1 and P-value < 0.05, respectively.
Np
a
NN ECV 1
b
ECV 1p
c
<< / ,
NN ECV 0.5
b
ECV p
c
<< / ., 05
NN ECV 0.1
b
ECV 0.1p
c
<< / ,BMC Bioinformatics 2004, 5:120 http://www.biomedcentral.com/1471-2105/5/120
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SNPs selected by PDM, 0.64 (23/36) for combinations
between the 10 selected SNPs and the remaining 15 SNPs,
and 0.08 (3/36) for combinations of the remaining 15
SNPs (Table 5). The random selection rate, Ncom/15P2
shown in Table 5, represents the rate which the combina-
tion is selected from all 2-SNP combinations independ-
ently, 0.15 (90/15P2) for the 10 SNPs selected by PDM, 0.5
(300/15P2) for combinations between the 10 selected
SNPs and the remaining 15 SNPs, and 0.35 (210/15P2) for
combinations of the remaining 15 SNPs (Table 5). The
concentration ratio was found to be 1.85 for the 10 SNPs
selected by PDM, 1.28 for combinations between the 10
selected SNPs and the remaining 15 SNPs, and 0.24 for
combinations of the remaining 15 SNPs (Table 5). The
concentration ratio was higher for combinations among
the 10 selected SNPs than for other combinations, so we
can select 2-SNP combinations associated with CAA with
high rate. The results are shown in Table 6.
In the next step, 3-SNP combinations were analyzed. The
effective rate, the random selection rate, and the concen-
tration ratio were calculated as well as the case of 2-SNP
combination (Table 5). It was found to be 2.28 for each of
the 10 selected SNPs alone (3:0 in Table 5), 1.33 for 2 of
the 10 selected SNPs and 1 of the remaining 15 SNPs (2:1
in Table 5), 0.67 for 1 of the 10 selected SNPs and 2 of the
Table 5: Number of effective combinations (Nef) and its concentration ratio.
2-SNP combination
10 SNPa:15 SNPb 2 : 0 1 : 1 0 : 2
Ncomb 90 300 210
10 23 3
0.28 0.64 0.08
0.15 0.5 0.35
1.85 1.28 0.24
3-SNP combination
10 SNPa : 15 SNPb 3 : 0 2 : 1 1 : 2 0 : 3
Ncomb 360 2025 3150 1365
25 82 64 39
0.12 0.39 0.30 0.19
0.05 0.29 0.46 0.20
2.28 1.33 0.67 0.94
aSelected by PDM
bNot including 10 SNP selected by PDM
cThe number of 2-SNP combination that satisfies the following conditions:P-value < 0.05 and ECV2<0.5.
The number of 3-SNP combination that satisfies the conditions: P-value < 0.05 and ECV3 < 0.5.
Nef
c
EffectiveRate
NN ef ef (/ ) ∑
RandomSelectionRate
Ncomb (/ ) 25P2
EffectiveRate
RandomSelectionRate
Nef
c
EffectiveRate
NN ef ef (/ ) ∑
RandomSelectionRate
Ncomb (/ ( / ) ) 25 3 2 p
EffectiveRate
RandomSelectionRateBMC Bioinformatics 2004, 5:120 http://www.biomedcentral.com/1471-2105/5/120
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remaining 15 SNPs (1:2 in Table 5), and 0.94 for the
remaining 15 SNPs alone (0:3 in Table 5). The concentra-
tion ratio was higher for combinations among the 10
selected SNPs than for other combinations, so we can
select 3-SNP combinations associated with CAA with high
rate. The combination with the lowest ECV3 consisted of
the genes IL-4Rα, and C3 (0.03526). This is about 3% of
the value multiplied each P-value of 2-SNP combination
(0.5060). For patients with genotype GA of IL-4Rα (148
G/A: Val50Ile) and genotype CT of C3 (4896 C/T), patient
frequency against genotype of C3 (1692 G/A) had a P-
value of 0.01784. For C3 (1692 G/A) alone, a P-value of
0.6993 was obtained, which was 40 times greater than the
P-value of the 3-SNP combination. Thus the rate of correct
identification of effective combinations evaluated by
adjusted P-value and ECV selected based on PDM trials
was higher than the corresponding randomized rate,
implying that the ANN can reliably select SNP combina-
tions that are associated with CAA.
The 2-SNP combinations with the conditions described
above among selected 10 SNPs are shown in Table 6. For
example, in Table 6, for combinations between CysLT2
(2534 A/G) and IL-4Rα (148 G/A: Val50Ile), among sub-
jects with a CysLT2 (2534 A/G) genotype of AG or GG
(CAA, 107 subjects; healthy controls, 103 subjects), there
was an important correlation with IL-4Rα  (148 G/A:
Val50Ile) genotype of GG, GA, AA (P  = 0.00030). We
examined the distributions of important combinations
among subjects. A total of 52 CAA subjects and 24 healthy
controls had genotype AG or GG at CysLT2 and genotype
GG at IL-4Rα (148 G/A) (Figure 5a).
The present findings also indicate that the 3-SNP combi-
nation consisting of IL-10 (-571 C/A), IL-4 (-590 C/T) and
C3  (1692 G/A) is a susceptible factor of CAA (P  =
0.00426). No association with CAA was found for any of
these 3 SNPs alone (P = 0.1074, 0.9085, 0.6993, respec-
tively; Table 1) or for any 2-SNP combinations of them (P
= 0.1851, and 0.3002, respectively). Subjects with geno-
type CA at IL-10 (-571 C/A), genotype CT at IL-4 (-590 C/
T) (CAA, 34 subjects; healthy controls, 38 subjects) and
genotype GG at C3 (1692 G/A) (CAA, 12 subjects; healthy
controls, 6 subjects) were estimated to be at high risk for
pathogenesis of CAA. Furthermore, among the subjects
with the same genotype pattern, the number of subjects
with genotype AA at C3 (1692 G/A) were CAA, 3 and
healthy controls, 13, respectively (Figure 5b).
Other remarkable combinations shown in Table 6 were
also found among the 10 selected SNPs. For example, the
number of cases with GG genotype at IL-4Rα (148G/A)
and TT genotype at C3 (4896C/T) was 4 times the number
of controls with that genotype combination (CAA, 20 sub-
jects; healthy controls, 5 subjects) (P = 0.00271). There are
no previous reports of association between these genotype
combinations and CAA. The combination of IL-4Rα (148
G/A: Val50Ile) and IL-4 (-590 C/T) was also associated
with CAA (P  = 0.00689); association between allergic
asthma and this combination has previously been
reported [15,16].
Discussion
To characterize the development mechanism, we investi-
gated several relationships between SNPs and develop-
ment of CAA, referring to previous papers, as described
below. IL-4 is produced by Th2 cells, and exerts its activity
by interacting with the receptor IL-4Rα, located on the
surface of B cells. It has been reported that the V50
(148G)/R551(1827G) combination of IL-4Rα polymor-
Table 6: Two-SNP interactions among the 10 selected SNPs (P-value < 0.05 and ECV2 < 0.5)
SNP 1 SNP 1 genotype SNP 2 Pa Pb Pc Pb × Pc Pa/(Pb × Pc)
C3 (4896 C/T) TT C3 (1692 G/A) 0.01461 0.7205 0.6993 0.5038 0.0290
CysLT2 (2534 A/G) AG+GG IL-4Rα (148 G/A) 0.00030 0.5664 0.0155 0.0088 0.0344
C3 (1692 G/A) AA C3 (4896 C/T) 0.02858 0.6993 0.7205 0.5038 0.0567
C3 (912 G/A) GG C3 (4896 C/T) 0.02345 0.5020 0.7205 0.3617 0.0648
C3 (4896 C/T) TT C3 (912 G/A) 0.03073 0.7205 0.5020 0.3617 0.0850
C3 (1692 G/A) GA CysLT2 (2534 A/G) 0.04917 0.6993 0.5664 0.3961 0.1241
STAT6 (2964 G/A) GG+GA IL-10 (-571 C/A) 0.01752 0.7881 0.1074 0.0846 0.2070
C3 (4896 C/T) TT IL-4Rα (148 G/A) 0.00271 0.7205 0.0155 0.0112 0.2426
C3 (912 G/A) GG IL-4Rα (148 G/A) 0.00345 0.5020 0.0155 0.0078 0.4442
IL-4 (-590 C/T) CT+TT IL-4Rα (148 G/A) 0.00689 0.9085 0.0155 0.0141 0.4896
aP-value of combination of SNP 2 with genotype consisting of SNP 1. In this case, D.F. of SNP 2 is identical to that of Table 1.
bP-value of SNP 1 calculated alone.
cP-value of SNP 2 calculated alone.
aP/(bP × cP) represents effective combination value (ECV2).BMC Bioinformatics 2004, 5:120 http://www.biomedcentral.com/1471-2105/5/120
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phisms may be associated with enhancement of IL-4Rα
function [16]. As concerns the polymorphisms on IL-4, it
was reported that the -590T allele increases the strength of
the IL-4 promoter compared with the -590C allele [15].
C3 is a proinflammatory mediator that binds to specific
cell surface receptors and causes leukocyte activation,
smooth muscle contraction and vascular permeability
[17].  C3-deficient mice challenged with allergen show
diminished airway hyperresponsiveness and lung eosi-
nophilia, with dramatic reduction of the number of IL-4-
producing cells and attenuation of IgE responses [18]. In
the present study, we found that interaction between gen-
otype TT at C3 (4896 C/T) and genotype GG at IL-4Rα
(148 G/A) may be associated with CAA, but details of
interaction between these polymorphisms combinations
and development mechanisms have not been clarified.
The present findings indicate that, among subjects with an
IL-10 (-571 C/A) genotype of CA and an IL-4 (-590 C/T)
genotype of CT, there is important correlation with a C3
(1692 G/A) genotype of GG or AA (Figure 5b).
CysLTs, which are produced by inflammatory cells includ-
ing eosinophils, are mediators of leukotrienes, and have
been implicated in the pathogenesis of allergic diseases.
Recently, it has been reported that CysLTs can act as auto-
crine or paracrine mediators to stimulate rapid, nonexocy-
totic release of IL-4 [19]. These findings are consistent
with the present results, in which subjects with CT or TT
genotype at IL-4 (-590 C/T), AG or GG genotype at CysLT2
(2534 A/G) and GG genotype at IL-4Rα (148 G/A) were
estimated to be at high risk for pathogenesis of CAA (P =
0.00022). However, 2-SNP interaction between CysLT2
(2534 A/G) and IL-4Rα (148 G/A) (P = 0.00030) mark-
edly affected the 3-SNP interaction.
In the present study, we examined correlation between
CAA and 25 SNPs in 17 genes using an ANN model. We
think that there are not a few main effects and interactions
which can explain development of multifactorial disease
like CAA, because it is thought that interactions of genetic
risk factors might be different individually among CAA
patients in spite of same disease. So it is very important to
select multiple genetic factor models associated with mul-
tifactorial disease like CAA with high concentration ratio.
We found that 10 of these SNPs are important factors in
development of CAA. Important combinations among
these 10 SNPs were also extracted. As described above,
several of these combinations (listed in Table 6 etc.) have
been found to be important factors in allergic disease, in
previous biological and epidemiological studies. We also
found several novel important combinations. The present
data about important combinations suggests multiple
patterns of CAA development. It should be noted that
these findings were obtained automatically using an ANN
model constructed without priori knowledge. Using an
ANN model with 10 SNPs, we were able to discriminate
between cases and controls with more than 70% accuracy.
We concluded that the ANN is an effective tool for predict-
ing development of CAA, using SNP data. However,
further investigation of other genetic and environmental
factors associated with CAA is needed. We previously
constructed an advanced modeling method, the fuzzy
neural network [20,21], which is an ANN model. When
this model is applied to analysis, the susceptibility rules of
interaction can be explicitly and linguistically described.
Also, it can be used to describe susceptible interaction
Distribution of IL-4Rα (148 G/A) genotype with CysLT2 (2534  A/G) genotype AG or GG (P = 0.00030) (a), and distribution  of C3 (1692 G/A) genotype with IL-10 (-571 C/A) genotype  CA and IL-4 (-590 C/T) genotype CT (P = 0.00426) (b) Figure 5
Distribution of IL-4Rα (148 G/A) genotype with CysLT2 (2534 
A/G) genotype AG or GG (P = 0.00030) (a), and distribution 
of C3 (1692 G/A) genotype with IL-10 (-571 C/A) genotype 
CA and IL-4 (-590 C/T) genotype CT (P = 0.00426) (b). Gray 
and white bars represent frequency of case subjects and con-
trol subjects, respectively.
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between genetic factors such as SNPs and environmental
factors such as favorite foods and life style. Using the rules
obtained with this model, we can plan protocols for pre-
ventive treatment of subjects with high-risk genetic pro-
files. Network analysis tools such as ANNs can be applied
to analysis of multifactorial disease using SNP data such
as selection of important SNPs or description of interac-
tions between SNPs.
Conclusions
Relationships between CAA and 25 SNPs in 17 candidate
genes were analyzed using an ANN. In diagnostic predic-
tion, ANN discriminated cases from controls more pre-
cisely than LR. From among the 25 original SNPs
analyzed, we selected 10 SNPs that were closely associated
with CAA. Calculating P-value using the χ2 test, we found
that 2-SNP and 3-SNP combinations of these 10 SNPs
were associated with CAA. The ANN was able to represent
associations between CAA and these 2-SNP or 3-SNP
combinations using complicated nonlinear relations.
Thus, the ANN can be used to characterize development
of complex diseases caused by multiple factors.
Methods
Subjects and SNP data
SNP data were kindly provided by the ethics committees
of Tohoku University and RIKEN. We analyzed the SNP
data for 25 polymorphisms in the 17 genetic regions listed
in Table 1. Each SNP was detected using the established
method based on TaqMan PCR [22]. The study popula-
tion comprised 172 subjects with childhood allergic
asthma (CAA) who were under 17 years of age and 172
healthy subjects with no signs or symptoms of atopy-
related diseases selected from general population, all of
whom gave written informed consent for SNP analysis.
The subjects were diagnosed by experienced doctors, as
"positive" (with allergic asthmatic symptoms) or "nega-
tive" (without allergic asthmatic symptoms). In the
present paper, the subjects with CAA are referred to as
"cases" and the healthy subjects are referred to as
"controls". Genotype patterns of the 25 SNPs were com-
pared between cases and controls. None of the cases had
genotype patterns coinciding with those of controls.
Data preprocessing
To use SNP data as input data for the ANN, we converted
the genotyping data into 2-numeral data. In ANN mode-
ling, input and output variables are normalized into 0.1–
0.9 [8]. In SNP data, there are 3 genotypes per locus.
Therefore, we provided 2 inputs per SNP: (0.1, 0.1) for
homozygote of the major allele, (0.1, 0.9) for heterozy-
gote, and (0.9, 0.9) for homozygote of the minor allele.
Since from the genetic point of view it may be difficult to
estimate that heterozygote affects a disease by half the
extent that homozygote affects it, the coding of (0.1),
(0.5) and (0.9) was never used. The diagnosis data were
also converted into numerical data, referred to hereafter as
"teacher" values: 0.9 for "positive (case)", and 0.1 for
"negative (control)".
For LR, we converted SNP data into numerical input data
as follows: (0.1, 0.1) for homozygote of the major allele,
(0.1, 0.9) for heterozygote, and (0.9, 0.9) for homozygote
of the minor allele. Positive and negative diagnoses were
also converted into numerical data: 0.9 and 0.1,
respectively.
ANN model and model construction
For SNP analysis, we used a three-layered ANN with input,
hidden and output layers (Figure 1). For model construc-
tion, the performance index of the ANN was assessed
using a method we previously proposed [7,8], with slight
modifications. Nerror (number of missed points) and Er
(sum of squared error) were defined and calculated for
learning data and evaluation data as follows:
Nerror = Nerror,l + Nerror,e   (3)
where  Y  and  T  represent the predicted value and the
teacher value, respectively. Nl  and  Ne  represent the
number of subjects as learning and evaluation data,
respectively. Nerror is the number of output data with an
error of >0.4 between the predicted value and teacher
value as shown above. Er is calculated with the square of
error as shown above. For ANN learning, the connection
weights were initially randomly set from 0 to 1, and were
altered using the back propagation methods [23] with
learning data so as to minimize the value of Erl. Learning
rates of 0.1, 0.2, 0.3, 0.4 and 0.5 were examined. The max-
imum learning time was 2000 iterations. The best ANN
model (selected for SNP analysis) was that in which Nerror
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reached minimum within the maximum learning time.
When minimum Nerror was equal to that of other models
within the maximum learning time, the model with min-
imum Er value was selected.
Prediction accuracy of the constructed model was defined
as follows. Threshold was set at 0.5. If the teacher value
was 0.9, and the predicted value was greater than 0.5, the
prediction was true (true positive; TP); for predicted val-
ues lower than 0.5, the prediction was false (false nega-
tive; FN). If the teacher value was 0.1, and the predicted
value was lower than 0.5, the prediction was true (true
negative; TN); for predicted values greater than 0.5, the
prediction was false (false positive; FP).
We calculated the prediction accuracy (Ac) as follows:
The sensitivity (Se) and specificity (Sp) of predicted values
were defined as follows:
where NTP, NFN, NTN and NFP are the number of TN, FN,
TN and FP subjects, respectively. Ncase and Ncontrol are the
number of case and control subjects, respectively.
Parameter Decreasing Method (PDM)
In order to extract SNPs closely associated with CAA, we
selected the input variables by parameter decreasing
method (PDM) after the ANN model with 25 SNPs was
constructed. In PDM, 1 SNP was excluded from input
variables in turn, and ANN models were constructed with
the remaining 24 SNPs by performing the cross-validation
described below. From among the 25 models thus con-
structed, the model with minimum Nerror averaged in the
cross-validation step was selected. When minimum Nerror
was equal to that of other models within the maximum
learning time, the model with minimum Er value was
selected as described above. The PDM step was repeated
until 1 SNP remained as input variable. The PDM proce-
dure was performed 5 times with unifying learning rates
of 0.1 and learning time of 2000, and the rank of impor-
tance of selected SNPs was determined as described in
Results section. We performed 5 PDM trials so that the
effects of randomized initial connection weights might be
minimized. In 5 PDM trials, data set for cross-validation
mentioned below was reconstructed every time.
Cross-validation
Cross-validation allows estimation of the prediction error
of a model by leaving out a portion of the data as an eval-
uation data [24]. In the present study, to investigate the
flexibility of the ANN, learning and evaluation were
performed using the ANN and 5-fold cross-validation.
With 5-fold cross-validation, the data set for the 172 cases
and 172 controls was divided into 5 groups with rand-
omizing and alternating the data. In each group, the
number of cases was equal to that of controls. Four groups
were assigned as learning data, and 1 group was assigned
as evaluation data; this learning and evaluation process
was repeated 5 times, so that each group was assessed
once as evaluation data. Then, the prediction accuracy of
evaluation data across all 5 trials was calculated and aver-
aged for the overall prediction accuracy of the ANN model
shown in Table 2. Sensitivity and specificity were also
calculated.
Logistic Regression (LR) Model
An LR model was constructed using SPSS 11.5J statistic
software for Windows (SPSS Japan Inc., Tokyo), for com-
parison with the ANN model. All 25 SNPs were used as
input variables of LR. For LR analysis, we used 50 main
effects plus an intercept but not any interaction terms. As
with the ANN model, the data set was divided into 5
groups and the cross-validation was performed. Predic-
tion accuracy, sensitivity and specificity were calculated.
Determination of differences in frequency of alleles and 
genotypes
We also examined association between CAA and combi-
nations of SNPs by calculating P-value using a χ2 test. The
χ2 test was used to evaluate the differences in frequencies
of alleles or genotypes between cases and controls. The P-
values shown in Table 1 were calculated using 172 cases
and 172 controls. Degree of freedom (D.F.) (shown in
Table 1) was 2 for 3 types of subjects; e.g., homozygote of
the major allele, heterozygote, and homozygote of the
minor allele. In the test with one SNP, when the expect-
ancy for subjects homozygous for the minor allele (calcu-
lated from the frequency of the genotype) was less than 5
subjects for both case and control, we regarded the
homozygote of the minor allele and the heterozygote as
identical and defined degree of freedom as 1. In the tests
with 2-SNP and 3-SNP combinations, we used the D.F.
shown in Table 1 to find the change of differences in fre-
quency under the same condition of SNP alone. If, in
more than 5 subjects, all expectancies for subjects satisfied
the test conditions, we calculated P-value with χ2 test. In
order to determine important combinations, we use two
evaluation bases (P-value and effective combination value
(ECV)) mentioned in Results section.
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